Skip to content

Medical-device intelligence

bioMerieux Inc: FDA clearances and recalls

Research bioMerieux Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

253 clearance records and 572 recall records in the covered releases, across 1 source company names and 88 product codes. Dated history runs from Feb 9, 1983 to Nov 4, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202601
February 202600
March 202600
April 202610
May 202600
June 202601
July 202611
August 202600
September 202600
October 202610

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

825 matching records
Device / recordCompany in FDA recordSourceSource date
ETEST IMIPENEM RELEBACTAM. in vitro diagnosticZ-2226-2021 · JWYBiomerieux IncRecallAug 6, 2021FDA record creation date
VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL)K201675 · LONbioMerieux, Inc.510(k)Jul 9, 2021FDA decision date
VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML)K211136 · LONbioMerieux, Inc.510(k)Jun 14, 2021FDA decision date
VIDAS CMV IgM 30 TestsZ-1408-2021 · LKQBiomerieux IncRecallApr 10, 2021FDA record creation date
VITEK 2 (version numbers 8.01, 8.02 (8.0x) and 9.01, 9.02 (9.0x) with the external communication configured to HL7 (system, test, automated, anti…Z-1307-2021 · LONBiomerieux IncRecallMar 25, 2021FDA record creation date
VITEK 2 Compact (version numbers 8.01, 8.02 (8.0x) and 9.01, 9.02 (9.0x) with the external communication configured to HL7 (system, test, automat…Z-1308-2021 · LONBiomerieux IncRecallMar 25, 2021FDA record creation date
VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL)K193299 · LONbioMerieux, Inc.510(k)Sep 28, 2020FDA decision date
VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL)K200590 · LONbioMerieux, Inc.510(k)Apr 28, 2020FDA decision date
PREVI Isola Insrument and PREVI Isola Printer spares PSUs (power supply units), P1028888-001 PSU (used in Zebra LP2824 Plus printers) PSUs wit…Z-1793-2020bioMerieux, Inc.RecallApr 23, 2020FDA record creation date
The VITEK 2 Gram-positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in-vitro test to determ…Z-1742-2020 · N/ABiomerieux IncRecallApr 17, 2020FDA record creation date
VITEK 2 card AST-N371 - Product Usage: The VITEK 2 is an automated system consisting of instruments, software, and reagent cards designed for the…Z-1534-2020 · N/AbioMerieux, Inc.RecallMar 20, 2020FDA record creation date
VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL)K193572 · LONbioMerieux, Inc.510(k)Mar 13, 2020FDA decision date
BIOMERIEUX VIDAS 3, Compact immunoanalyzer with full traceability and automationZ-0928-2020 · JJEBiomerieux IncRecallMar 2, 2020FDA record creation date
VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 – >=16 ug/mL)K193567 · LONbioMerieux, Inc.510(k)Feb 14, 2020FDA decision date
VIDAS Varicella Zoster IgG (VZG) antibody IVD, kitZ-1107-2020 · LFYbioMerieux, Inc.RecallFeb 7, 2020FDA record creation date
Vitek DensichekK192110 · LONbioMerieux, Inc.510(k)Oct 31, 2019FDA decision date
VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL)K191766 · LONbioMerieux, Inc.510(k)Aug 5, 2019FDA decision date
VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL)K190616 · LONbioMerieux, Inc.510(k)Jun 6, 2019FDA decision date
BACT/ALERT MP Reagent SystemK190405 · MDBbioMerieux, Inc.510(k)May 15, 2019FDA decision date
Biomerieux Vitek 2 Test kit VITEK 2 is an automated system consisting of instruments, software and reagent cards designed for the identificatio…Z-1137-2019 · LONbioMerieux, Inc.RecallApr 12, 2019FDA record creation date
VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL)K183524 · LONbioMerieux, Inc.510(k)Mar 12, 2019FDA decision date
VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL)K183551 · LONbioMerieux, Inc.510(k)Mar 7, 2019FDA decision date
VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 – >=64/8 µg/mL)K183360 · LONbioMerieux, Inc.510(k)Feb 26, 2019FDA decision date
VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL)K183415 · LONbioMerieux, Inc.510(k)Feb 20, 2019FDA decision date
VITEK 2 AST-N351 Test KitZ-0847-2019 · LONbioMerieux, Inc.RecallFeb 16, 2019FDA record creation date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗